← All stocks

Gilead Sciences

GILD Mostly scheduled
CIK 0000882095 #222 in the set updated 17 Sep 2026
Bought (120 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$419.48M
$42.31M on a plan · $366.22M straight out of an exercise
Sold at will
$10.95M
27 of 303 sales
Net
−$419.48M
−$10.95M against sales at will

By person

34 insiders · 311 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
MARTIN JOHN C
Director
$131.54M (51) scheduled
−$131.54M
2,887,225
0.2328%
$419.48M
−7.8%
Dickinson Andrew D
Chief Financial Officer
$62.18M (31) scheduled
−$62.18M
164,096
0.0132%
$23.84M
O'Day Daniel Patrick
Chairman & CEO
$55.82M (35) scheduled
−$55.82M
581,683
0.0469%
$84.51M
Mercier Johanna
Chief Comm & Corp Aff Officer
$31.91M (42) scheduled
−$31.91M
116,684
0.0094%
$16.95M
Alton Gregg H
Chief Patient Officer
$25.70M (31) scheduled
−$25.70M
58,046
0.0047%
$8.43M
−61.9%
Parsey Merdad
Chief Medical Officer
$22.24M (19) scheduled
−$22.24M
82,850
0.0067%
$12.04M
MILLIGAN JOHN F
President and CEO
$16.03M (1) scheduled
−$16.03M
1,574,306
0.1270%
$228.73M
+48.7%
Meyers James R
EVP Worldwide Commercial Ops
$13.02M (4) scheduled
−$13.02M
137,476
0.0111%
$19.97M
+7.5%
Pletcher Brett A
EVP,Corp Affairs & Gen Counsel
$9.34M (24) scheduled
−$9.34M
33,426
0.0027%
$4.86M
+373.7%
WILSON GAYLE E
Director
$8.84M (4) scheduled
−$8.84M
129,052
0.0104%
$18.75M
+22.5%
MADIGAN JOHN W
Director
$7.86M (1) scheduled
−$7.86M
18,548
0.0015%
$2.69M
+10.7%
Cogan John Francis
Director
$7.52M (28) scheduled
−$7.52M
54,860
0.0044%
$7.97M
+19.8%
Telman Deborah H
EVP, Corporate Affairs & GC
$6.59M (3) scheduled
−$6.59M
43,676
0.0035%
$6.35M
+6,538%
Washington Robin L
EVP, CFO
$4.81M (3) scheduled
−$4.81M
138,943
0.0112%
$20.19M
+6.1%
Wilfong Diane E.
Interim Corp Controller & CAO
$3.79M (4) scheduled
−$3.79M
46,259
0.0037%
$6.72M
+137.5%
WOLD OLSEN PER
Director
$3.19M (3) scheduled
−$3.19M
102,060
0.0082%
$14.83M
+11.5%
Bluestone Jeffrey
Director
$3.14M (9) scheduled
−$3.14M
10,066
0.0008%
$1.46M
WELTERS ANTHONY
Director
$2.68M (4) scheduled
−$2.68M
12,894
0.0010%
$1.87M
Whitley Richard James
Director
$2.55M (3) scheduled
−$2.55M
33,058
0.0027%
$4.80M
+31.5%
Kramer Kelly A.
Director
$713.19K (2) scheduled
−$713.19K
1,339
0.0001%
$194.54K
Rodriguez Javier
Director
$14.27K (1)
−$14.27K
13,364
0.0011%
$1.94M
+6,971%
BISCHOFBERGER NORBERT W
EVP, R&D and CSO
2,337,402
0.1885%
$339.60M
−0.1%
Lofton Kevin E
Director
101,095
0.0082%
$14.69M
+174.9%
Patterson Sandra
SVP, Controllership
39,453
0.0032%
$5.73M
+59.4%
McHutchison John G
Chief Scientific Off/HeadR&D
37,828
0.0031%
$5.50M
+65.1%
BARTON JACQUELINE K
Director
27,202
0.0022%
$3.95M
+105.1%
YOUNG KEVIN
Chief Operating Officer
25,612
0.0021%
$3.72M
+1,531%
Berger Dietmar
Chief Medical Officer
19,522
0.0016%
$2.84M
MANWANI HARISH
Director
15,015
0.0012%
$2.18M
MOORE NICHOLAS G
Director
12,233
0.0010%
$1.78M
−20.0%
Cain Wettan Keeley M
EVP Gen Counsel, Legal & Comp
8,759
0.0007%
$1.27M
+122.1%
Hamill Laura
EVP, Worldwide Commercial Ops
6,340
0.0005%
$921.14K
Horning Sandra
Director
6,293
0.0005%
$914.31K
LOVE TED W
Director
5,484
0.0004%
$796.77K
Insider
Date
Role
Action
Shares
Price
Amount
Parsey Merdad
13 Mar 2023
Chief Medical Officer
Sell
6,126
$78.99
$483.89K
Parsey Merdad
1 Mar 2023
Chief Medical Officer
Sell
12,984
$79.96
$1.04M
Parsey Merdad
30 Dec 2022
Chief Medical Officer
Sell
553
$85.33
$47.19K
Pletcher Brett A
11 Mar 2022
EVP,Corp Affairs & Gen Counsel
Sell
3,634
$58.24
$211.64K
Pletcher Brett A
9 Feb 2022
EVP,Corp Affairs & Gen Counsel
Sell
1,691
$63.89
$108.04K
Pletcher Brett A
1 Feb 2022
EVP,Corp Affairs & Gen Counsel
Sell
14,061
$68.54
$963.68K
Mercier Johanna
4 May 2021
Chief Commercial Officer
Sell
19,496
$66.09
$1.29M
Pletcher Brett A
11 Mar 2021
EVP,Corp Affairs & Gen Counsel
Sell
1,486
$63.36
$94.15K
Pletcher Brett A
10 Feb 2021
EVP,Corp Affairs & Gen Counsel
Sell
1,975
$67.41
$133.13K
Pletcher Brett A
1 Feb 2021
EVP,Corp Affairs & Gen Counsel
Sell
9,711
$65.97
$640.63K
Parsey Merdad
17 Aug 2020
Chief Medical Officer
Sell
182
$68.32
$12.43K
Rodriguez Javier
23 Jun 2020
Director
Sell
189
$75.50
$14.27K
Pletcher Brett A
2 Mar 2020
EVP,Corp Affairs & Gen Counsel
Sell
1,100
$71.26
$78.38K
Pletcher Brett A
2 Mar 2020
EVP,Corp Affairs & Gen Counsel
Sell
9,341
$70.83
$661.63K
Pletcher Brett A
7 Feb 2020
EVP,Corp Affairs & Gen Counsel
Sell
1,426
$70.00
$99.82K
Pletcher Brett A
5 Nov 2019
EVP,Corp Affairs & Gen Counsel
Sell
2,095
$66.06
$138.40K
Pletcher Brett A
28 Oct 2019
EVP, Gen Counsel & Corp Sec
Sell
5,677
$63.31
$359.41K
Pletcher Brett A
19 Aug 2019
EVP, Gen Counsel & Corp Sec
Sell
608
$64.35
$39.12K
Pletcher Brett A
18 Jun 2019
EVP, Gen Counsel & Corp Sec
Sell
5,816
$68.75
$399.85K
Washington Robin L
28 Feb 2018
EVP, CFO
Sell indirect
5,000
$80.31
$401.57K
Alton Gregg H
20 Feb 2018
EVP,Corporate &Medical Affairs
Sell indirect
14,435
$81.54
$1.18M
Showing 250 of 311 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 667
Amendments (4/A) skipped 2
Filings about a different issuer 15
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 86
Sales straight out of an exercise 190
Sales at will 27
Transactions with no price 0
Shares from compensation/vesting 9,830,734
Sales filed before the plan box existed 27
History held since 31 Aug 2016